Healthcare ❯Pharmaceuticals ❯Vaccine Development

Clinical Trials

Global Expansion TPOXX Efficacy and Safety

Health Canada Approves Moderna's Updated COVID-19 Vaccine

The new SpikeVAX targets the KP.2 variant as provinces prepare for fall vaccination campaigns.

FDA Expands Approval of GSK's RSV Vaccine to Adults Aged 50-59